GLH Stock Overview
Global Health Limited provides digital health solutions for the healthcare sector in Australia.
Capture your thoughts, links and company narrative
Global Health Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.17|
|52 Week High||AU$0.44|
|52 Week Low||AU$0.14|
|1 Month Change||0%|
|3 Month Change||n/a|
|1 Year Change||-39.29%|
|3 Year Change||25.93%|
|5 Year Change||-29.17%|
|Change since IPO||-70.18%|
Recent News & Updates
|GLH||AU Healthcare Services||AU Market|
Return vs Industry: GLH underperformed the Australian Healthcare Services industry which returned 17.2% over the past year.
Return vs Market: GLH underperformed the Australian Market which returned -9.2% over the past year.
|GLH Average Weekly Movement||n/a|
|Healthcare Services Industry Average Movement||10.1%|
|Market Average Movement||8.3%|
|10% most volatile stocks in AU Market||14.5%|
|10% least volatile stocks in AU Market||3.6%|
Stable Share Price: Insufficient data to determine GLH's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine GLH's volatility change over the past year.
About the Company
|1985||n/a||Alumootil Mathew Cherian||https://www.global-health.com|
Global Health Limited provides digital health solutions for the healthcare sector in Australia. It provides mental health software for psychologists and psychiatrists; and integrated software solutions for various areas of community health and human services, including drug and alcohol, disability, post-acute care, community care, mental health services, and community rehabilitation, as well as offers software solutions for home care and aged care, consumer engagement tools, general practice, and pharmacy. The company’s products include MasterCare EMR, an Electronic Medical Record; MasterCare + that helps organizations in digitizing their services and processes; MasterCare PAS, a patient administration system; PrimaryClinic, a medical and practice management software for general practitioners and specialists that share the same patient demographic.
Global Health Limited Fundamentals Summary
|GLH fundamental statistics|
Is GLH overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|GLH income statement (TTM)|
|Cost of Revenue||AU$8.07m|
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.058|
|Net Profit Margin||-49.59%|
How did GLH perform over the long term?See historical performance and comparison